These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21628141)

  • 21. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic impact of converting from 10-mL insulin vials to 3-mL vials and pens in a hospital setting.
    Edmondson G; Criswell J; Krueger L; Eby EL
    Am J Health Syst Pharm; 2014 Sep; 71(17):1485-9. PubMed ID: 25147173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.
    Eby EL; Boye KS; Lage MJ
    J Med Econ; 2013 Oct; 16(10):1231-7. PubMed ID: 23834480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals.
    Pfützner A; Bailey T; Campos C; Kahn D; Ambers E; Niemeyer M; Guerrero G; Klonoff D; Nayberg I
    Curr Med Res Opin; 2013 May; 29(5):475-81. PubMed ID: 23402225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic Impact of Converting from Pen and 10-mL Vial to 3-mL Vial for Insulin Delivery in a Hospital Setting.
    Elizabeth E; Smolen L; Pitts A; Krueger LA; Grimm D
    Hosp Pharm; 2014 Dec; 49(11):1033-8. PubMed ID: 25673892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin 70/30 with US-licensed HUMULIN® 70/30 formulation in healthy subjects: Results from the RHINE-3 (Recombinant Human INsulin Equivalence-3) study.
    Plum-Mörschel L; Klein O; Singh G; Murugesan SMN; Marwah A; Sharma N; Panda J; Loganathan S; Lakshmi GC; Athalye SN
    Diabetes Obes Metab; 2022 Sep; 24(9):1819-1828. PubMed ID: 35589611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills.
    Pfützner A; Schipper C; Niemeyer M; Qvist M; Löffler A; Forst T; Musholt PB
    J Diabetes Sci Technol; 2012 Jul; 6(4):910-6. PubMed ID: 22920818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of patient satisfaction with a prefilled insulin injection device in patients with type 1 and type 2 diabetes.
    Siegmund T
    J Diabetes Sci Technol; 2011 Sep; 5(5):1235-7. PubMed ID: 22027324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes.
    Bastian MD; Wolters NE; Bright DR
    Consult Pharm; 2011 Jun; 26(6):426-9. PubMed ID: 21628141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin pens vs. vials and syringes: the pharmacist's role in individualizing therapy.
    Honebrink AN; Peters CR; Bright DR
    Consult Pharm; 2011 Jul; 26(7):491-3. PubMed ID: 21729850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations for diabetes: treatment with insulin pen devices.
    Cuddihy RM; Borgman SK
    Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens.
    Oyer D; Niemeyer M; Moses A
    Postgrad Med; 2012 Sep; 124(5):110-20. PubMed ID: 23095431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.
    Davis EM; Christensen CM; Nystrom KK; Foral PA; Destache C
    Am J Health Syst Pharm; 2008 Jul; 65(14):1347-57. PubMed ID: 18593681
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.